These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging. Tang D, McKinley ET, Hight MR, Uddin MI, Harp JM, Fu A, Nickels ML, Buck JR, Manning HC. J Med Chem; 2013 Apr 25; 56(8):3429-33. PubMed ID: 23521048 [Abstract] [Full Text] [Related]
9. Evaluation of PET Imaging Performance of the TSPO Radioligand [18F]DPA-714 in Mouse and Rat Models of Cancer and Inflammation. Zheng J, Winkeler A, Peyronneau MA, Dollé F, Boisgard R. Mol Imaging Biol; 2016 Feb 25; 18(1):127-34. PubMed ID: 26194010 [Abstract] [Full Text] [Related]
14. Longitudinal 18F-VUIIS1008 PET imaging in a rat model of rheumatoid arthritis. Su X, Wang L, Yang R, Guo Z. Front Chem; 2022 Feb 25; 10():1064518. PubMed ID: 36618864 [Abstract] [Full Text] [Related]
15. TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma. Pigeon H, Pérès EA, Truillet C, Jego B, Boumezbeur F, Caillé F, Zinnhardt B, Jacobs AH, Le Bihan D, Winkeler A. Neuro Oncol; 2019 Jun 10; 21(6):755-764. PubMed ID: 30721979 [Abstract] [Full Text] [Related]
16. Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study. Buck JR, McKinley ET, Fu A, Abel TW, Thompson RC, Chambless L, Watchmaker JM, Harty JP, Cooper MK, Manning HC. PLoS One; 2015 Jun 10; 10(10):e0141659. PubMed ID: 26517124 [Abstract] [Full Text] [Related]
17. Development of a 18F-Labeled Radiotracer with Improved Brain Kinetics for Positron Emission Tomography Imaging of Translocator Protein (18 kDa) in Ischemic Brain and Glioma. Fujinaga M, Luo R, Kumata K, Zhang Y, Hatori A, Yamasaki T, Xie L, Mori W, Kurihara Y, Ogawa M, Nengaki N, Wang F, Zhang MR. J Med Chem; 2017 May 11; 60(9):4047-4061. PubMed ID: 28422499 [Abstract] [Full Text] [Related]